Functional symbiosis between the intermediate filament cytoskeleton and small heat shock proteins

Small Stress Proteins and Human Diseases

Volumn , Issue , 2011, Pages 55-87

  Landsbury, Andrew ^a   Perng, Ming Der ^b   Pohl, Ehmke ^a   Quinlan, Roy A ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895325708     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (230)

1. Erickson HP. Evolution of the cytoskeleton. Bioessays. 2007 Jul;29(7):668-77.
2. Weaver VM, Carson CE, Walker PR, Chaly N, Lach B, Raymond Y, et al. Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J Cell Sci. 1996;109(Pt 1):45-56.
3. Charbon G, Cabeen MT, Jacobs-Wagner C. Bacterial intermediate filaments: in vivo assembly, organization, and dynamics of crescentin. Genes Dev. 2009 May 1;23(9):1131-44.
4. Vats P, Shih YL, Rothfield L. Assembly of the MreB-associated cytoskeletal ring of Escherichia coli. Mol Microbiol. 2009 Apr;72(1):170-82.
5. Ebersbach G, Galli E, Moller-Jensen J, Lowe J, Gerdes K. Novel coiled-coil cell division factor ZapB stimulates Z ring assembly and cell division. Mol Microbiol. 2008 May;68(3):720-35.
6. Bagchi S, Tomenius H, Belova LM, Ausmees N. Intermediate filament-like proteins in bacteria and a cytoskeletal function in Streptomyces. Mol Microbiol. 2008 Nov;70(4):1037-50.
7. Perng MD, Cairns L, van den IP, Prescott A, Hutcheson AM, Quinlan RA. Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J Cell Sci. 1999 Jul;112 (Pt 13):2099-112.
8. Perng MD, Wen SF, Gibbon T, Middeldorp J, Sluijs JA, Hol EM, et al. GFAP Filaments Can Tolerate the Incorporation of Assembly-compromised GFAP-{delta}, but with Consequences for Filament Organization and {alpha}B-crystallin Association. Mol Biol Cell, 2008 Aug 13.
9. Quinlan R. Cytoskeletal competence requires protein chaperones. Prog Mol Subcell Biol. 2002;28:219-33.
10. Cabeen MT, Charbon G, Vollmer W, Born P, Ausmees N, Weibel DB, et al. Bacterial cell curvature through mechanical control of cell growth. EMBO J. 2009 May 6;28(9):1208-19.
11. Claessen D, de Jong W, Dijkhuizen L, Wosten HA. Regulation of Streptomyces development: reach for the sky! Trends Microbiol. 2006 Jul;14(7):313-9.
12. Kemp MW, Edwards B, Burgess M, Clarke WT, Nicholson G, Parry DA, et al. Syncoilin isoform organization and differential expression in murine striated muscle. J Struct Biol. 2009 Mar;165(3):196-203.
13. Newey SE, Howman EV, Ponting CP, Benson MA, Nawrotzki R, Loh NY, et al. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. J Biol Chem. 2001 Mar 2;276(9):6645-55.
14. Pekny M, Lane EB. Intermediate filaments and stress. Exp Cell Res. 2007 Jun 10;313(10):2244-54.
15. Engl C, Jovanovic G, Lloyd LJ, Murray H, Spitaler M, Ying L, et al. In vivo localizations of membrane stress controllers PspA and PspG in Escherichia coli. Mol Microbiol. 2009 Jun 26.
16. Goldberg MW, Fiserova J, Huttenlauch I, Stick R. A new model for nuclear lamina organization. Biochem Soc Trans. 2008 Dec;36(Pt 6):1339-43.
17. Franke WW, Hergt M, Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell, 1987;49(1):131-41.
18. Sandilands A, Prescott AR, Carter JM, Hutcheson AM, Quinlan RA, Richards J, et al. Vimentin and CP49 / Filensin form distinct networks in the lens which are independantly modulated during lens fibre cell differentiation. J Cell Sci. 1995;108:1397-406.
19. Song S, Landsbury A, Dahm R, Liu Y, Zhang Q, Quinlan RA. Functions of the intermediate filament cytoskeleton in the eye lens. J Clin Invest. 2009 Jul;119(7):1837-48.
20. Bellin RM, Huiatt TW, Critchley DR, Robson RM. Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres. J Biol Chem. 2001 Aug 24;276(34):32330-7.
21. Janmey PA, Winer JP, Murray ME, Wen Q. The hard life of soft cells. Cell Motil Cytoskeleton, 2009 May 28.
22. Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007 Jul 1;21(13):1581-97.
23. Vogel V, Sheetz MP. Cell fate regulation by coupling mechanical cycles to biochemical signaling pathways. Curr Opin Cell Biol. 2009 Feb;21(1):38-46.
24. Herrmann H, Strelkov SV, Burkhard P, Aebi U. Intermediate filaments: primary determinants of cell architecture and plasticity. J Clin Invest. 2009 Jul;119(7):1772-83.
25. Dichtl MA, Sackmann E. Microrheometry of semiflexible actin networks through enforced single-filament reptation: frictional coupling and heterogeneities in entangled networks. Proc Natl Acad Sci U S A. 2002 May 14;99(10):6533-8.
26. Perng MD, Wen SF, van den IP, Prescott AR, Quinlan RA. Desmin aggregate formation by R120G alphaB-crystallin is caused by altered filament interactions and is dependent upon network status in cells. Mol Biol Cell,. 2004 May;15(5):2335-46.
27. Vicart P, Caron A, Guicheney P, Li Z, Prevost MC, Faure A, et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998;20(1):92-5.
28. Reiter T, Penman S. "Prompt" heat shock proteins: translationally regulated synthesis of new proteins associated with the nuclear matrix-intermediate filaments as an early response to heat shock. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4737-41.
29. Dynlacht JR, Story MD, Zhu WG, Danner J. Lamin B is a prompt heat shock protein. J Cell Physiol. 1999 Jan;178(1):28-34.
30. Haddad N, Paulin-Levasseur M. Effects of heat shock on the distribution and expression levels of nuclear proteins in HeLa S3 cells. J Cell Biochem. 2008 Dec 15;105(6):1485-500.
31. Wisniewski T, Goldman JE. alpha B-crystallin is associated with intermediate filaments in astrocytoma cells. Neurochemical Research, 1998;23(3):385-92.
32. van den Ijssel P, Wheelock R, Prescott A, Russell P, Quinlan RA. Nuclear speckle localisation of the small heat shock protein alpha B-crystallin and its inhibition by the R120G cardiomyopathy-linked mutation. Exp Cell Res. 2003 Jul 15;287(2):249-61.
33. Adhikari AS, Sridhar Rao K, Rangaraj N, Parnaik VK, Mohan Rao C. Heat stress-induced localization of small heat shock proteins in mouse myoblasts: intranuclear lamin A/C speckles as target for alphaB-crystallin and Hsp25. Exp Cell Res. 2004 Oct 1;299(2):393-403.
34. Kato K, Goto S, Hasegawa K, Shinohara H, Inaguma Y. Responses to heat shock of alpha B crystallin and HSP28 in U373 MG human glioma cells. Biochim Biophys Acta, 1993;1175(3):257-62.
35. Chiesi M, Longoni S, Limbruno U. Cardiac alpha-crystallin. III. Involvement during heart ischemia. Mol Cell Biochem. 1990;97(2):129-36.
36. Golenhofen N, Htun P, Ness W, Koob R, Schaper W, Drenckhahn D. Binding of the stress protein alpha B-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. J Mol Cell Cardiol. 1999; 31(3):569-80.
37. Iwaki T, Kume-Iwaki A, Liem RKH, Goldman JE. AB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell. 1989;57:71-8.
38. Iwaki T, Iwaki A, Tateishi J, Sakaki Y, Goldman JE. Alpha-b-crystallin and 27-kd heat-shock protein are regulated by stress conditions in the central-nervous-system and accumulate in rosenthal fibers. Am J Path. 1993; 143(2):487-95.
39. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ. Alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol. 1992 Jan; 166(1):61-8.
40. Djabali K, deNechaud B, Landon F, Portier MM. alpha B-crystallin interacts with intermediate filaments in response to stress. J Cell Sci. 1997;110(Pt 21):2759-69.
41. Klemenz R, Frohli E, Steiger RH, Schafer R, Aoyama A. Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci U S A. 1991; 88(9):3652-6.
42. Wiesmann KE, Coop A, Goode D, Hepburne-Scott HW, Crabbe MJ. Effect of mutations of murine lens alphaB crystallin on transfected neural cell viability and cellular translocation in response to stress. FEBS Lett. 1998 Oct 30;438(1-2):25-31.
43. Bryantsev AL, Kurchashova SY, Golyshev SA, Polyakov VY, Wunderink HF, Kanon B, et al. Regulation of stress-induced intracellular sorting and chaperone function of Hsp27 (HspB1) in mammalian cells. Biochem J. 2007 Nov 1;407(3):407-17.
44. Nicholl ID, Quinlan RA. Chaperone activity of a-crystallins modulates intermediate filament assembly. EMBO J. 1994;13:945-53.
45. Altamirano MM, Garcia C, Possani LD, Fersht AR. Oxidative refolding chromatography: folding of the scorpion toxin Cn5 [see comments]. Nat Biotechnol. 1999;17(2):187-91.
46. Altamirano MM, Golbik R, Zahn R, Buckle AM, Fersht AR. Refolding chromatography with immobilized mini-chaperones. Proc Natl Acad Sci U S A. 1997;94(8):3576-8.
47. Muchowski PJ, Valdez MM, Clark JI. aB-crystallin selectively targets intermediate filament proteins during thermal stress. Invest Ophthalmol Vis Sci. 1999;40:951-8.
48. Perng MD, Muchowski PJ, van den Ijssel P, Wu GJS, Clark JI, Quinlan RA. The cardiomyopathy and lens cataract mutation in aB-crystallin compromises secondary, tertiary and quaternary protein structure and reduces in vitro chaperone activity. J Biol Chem. 1999; 274:33235-43.
49. Liu J, Tang M, Mestril R, Wang X. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J Mol Cell Cardiol. 2006 Apr; 40(4):451-4.
50. Tannous P, Zhu H, Johnstone JL, Shelton JM, Rajasekaran NS, Benjamin IJ, et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A. 2008 Jul 15; 105(28):9745-50.
51. Tang G, Yue Z, Talloczy Z, Goldman JE. Adaptive autophagy in Alexander disease-affected astrocytes. Autophagy, 2008 Sep-Oct;4(5):701-3.
52. Liu J, Chen Q, Huang W, Horak KM, Zheng H, Mestril R, et al. Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J. 2006 Feb; 20(2):362-4.
53. Cho W, Messing A. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Exp Cell Res. 2009 Apr 15; 315(7):1260-72.
54. Yoneda K, Furukawa T, Zheng YJ, Momoi T, Izawa I, Inagaki M, et al. An autocrine/paracrine loop linking keratin 14 aggregates to tumor necrosis factor alpha-mediated cytotoxicity in a keratinocyte model of epidermolysis bullosa simplex. J Biol Chem. 2004 Feb 20; 279(8):7296-303.
55. Harada M, Strnad P, Toivola DM, Omary MB. Autophagy modulates keratin-containing inclusion formation and apoptosis in cell culture in a context-dependent fashion. Exp Cell Res. 2008 May 1; 314(8):1753-64.
56. Ku NO, Omary MB. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J Cell Biol. 2000 May 1; 149(3):547-52.
57. Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A, et al. Desmin-related cardiomyopathy in transgenic mice: A cardiac amyloidosis. Proc Natl Acad Sci U S A. 2004 Jul 6; 101(27):10132-6.
58. Meehan S, Knowles TP, Baldwin AJ, Smith JF, Squires AM, Clements P, et al. Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins. J Mol Biol. 2007 Sep 14; 372(2):470-84.
59. Chen Q, Liu JB, Horak KM, Zheng H, Kumarapeli AR, Li J, et al. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res. 2005 Nov 11;97(10):1018-26.
60. Ito H, Kamei K, Iwamoto I, Inaguma Y, Garcia-Mata R, Sztul E, et al. Inhibition of Proteasomes Induces Accumulation, Phosphorylation, and Recruitment of HSP27 and alphaB-Crystallin to Aggresomes. J Biochem. (Tokyo). 2002 Apr; 131(4):593-603.
61. Bardag-Gorce F, Vu J, Nan L, Riley N, Li J, French SW. Proteasome inhibition induces cytokeratin accumulation in vivo. Exp Mol Pathol. 2004 Apr; 76(2):83-9.
62. Nitahara-Kasahara Y, Fukasawa M, Shinkai-Ouchi F, Sato S, Suzuki T, Murakami K, et al. Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. Virology, 2009 Jan 20; 383(2):319-27.
63. den Engelsman J, Bennink EJ, Doerwald L, Onnekink C, Wunderink L, Andley UP, et al. Mimicking phosphorylation of the small heat-shock protein alphaB-crystallin recruits the F-box protein FBX4 to nuclear SC35 speckles. Eur J Biochem. 2004 Nov; 271(21):4195-203.
64. Hayes VH, Devlin G, Quinlan RA. Truncation of alphaB-crystallin by the myopathy-causing Q151X mutation significantly destabilizes the protein leading to aggregate formation in transfected cells. J Biol Chem. 2008 Apr 18;283(16):10500-12.
65. Ghosh JG, Houck SA, Clark JI. Interactive sequences in the stress protein and molecular chaperone human alphaB crystallin recognize and modulate the assembly of filaments. Int J Biochem Cell Biol. 2007; 39(10):1804-15.
66. Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol. 2003 Dec; 54(6):804-10.
67. Meehan S, Knowles TP, Baldwin AJ, Smith JF, Squires AM, Clements P, et al. Characterisation of Amyloid Fibril Formation by Small Heat-shock Chaperone Proteins Human alphaA-, alphaB- and R120G alphaB-Crystallins. J Mol Biol. 2007 Jun 29.
68. Treweek TM, Rekas A, Lindner RA, Walker MJ, Aquilina JA, Robinson CV, et al. R120G alphaB-crystallin promotes the unfolding of reduced alpha-lactalbumin and is inherently unstable. Febs J. 2005 Feb; 272(3):711-24.
69. Goldfarb LG, Park KY, Cervenakova L, Gorokhova S, Lee HS, Vasconcelos O, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet. 1998; 19(4):402-3.
70. Goldfarb LG, Dalakas MC. Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest. 2009 Jul;119(7):1806-13.
71. Bar H, Mucke N, Kostareva A, Sjoberg G, Aebi U, Herrmann H. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15099-104.
72. Kreplak L, Bar H. Severe myopathy mutations modify the nanomechanics of desmin intermediate filaments. J Mol Biol. 2009 Jan 30;385(4):1043-51.
73. Goldfarb LG, Olive M, Vicart P, Goebel HH. Intermediate filament diseases: desminopathy. Adv Exp Med Biol. 2008; 642:131-64.
74. Schroder R, Schoser B. Myofibrillar myopathies: a clinical and myopathological guide. Brain Pathol. 2009 Jul; 19(3):483-92.
75. Quinlan RA, Brenner M, Goldman JE, Messing A. GFAP and its role in Alexander disease. Exp Cell Res. 2007 Jun 10;313(10):2077-87.
76. Li R, Johnson AB, Salomons G, Goldman JE, Naidu S, Quinlan R, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol. 2005 Mar;57(3):310-26.
77. Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, Verpoorten N, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet. 2004 Jun; 36(6):597-601.
78. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, Leung CL, et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet. 2004 Jun; 36(6):602-6.
79. Hagemann TL, Boelens WC, Wawrousek EF, Messing A. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hum Mol Genet. 2009 Apr 1; 18(7):1190-9.
80. Brenner M, Johnson AB, Boespflug-Tanguay O, Rodriguez D, Goldman JE. Mutations in GFAP, encoding glial fibrillary acidic protein are associated with Alexander Disease. Nat Gen. 2001;27:117-20.
81. Der Perng M, Su M, Wen SF, Li R, Gibbon T, Prescott AR, et al. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27. Am J Hum Genet. 2006 Aug;79(2):197-213.
82. Tang G, Xu Z, Goldman JE. Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J Biol Chem. 2006 Dec 15; 281(50):38634-43.
83. Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Path. 1998; 152(2):391-8.
84. Bensch KG, Fleming JE, Lohmann W. The role of ascorbic acid in senile cataract. Proc Natl Acad Sci U S A. 1985;82(21):7193-6.
85. Hsiao VC, Tian R, Long H, Der Perng M, Brenner M, Quinlan RA, et al. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J Cell Sci. 2005 May 1;118(Pt 9):2057-65.
86. Tian R, Gregor M, Wiche G, Goldman JE. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am J Pathol. 2006 Mar;168(3):888-97.
87. Koyama Y, Goldman JE. Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin [In Process Citation]. Am J Pathol. 1999; 154(5):1563-72.
88. Wang X, Klevitsky R, Huang W, Glasford J, Li F, Robbins J. AlphaB-crystallin modulates protein aggregation of abnormal desmin. Circ Res. 2003 Nov 14;93(10):998-1005.
89. Sanbe A, Daicho T, Mizutani R, Endo T, Miyauchi N, Yamauchi J, et al. Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy. PLoS One, 2009;4(4):e5351.
90. Sanbe A, Osinska H, Villa C, Gulick J, Klevitsky R, Glabe CG, et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A. 2005 Sep 20; 102(38):13592-7.
91. Miron T, Wilchek M, Geiger B. Characterization of an inhibitor of actin polymerization in vinculin- rich fraction of turkey gizzard smooth-muscle. Eur J Biochem. 1988; 178(2):543-53.
92. Mounier N, Arrigo AP. Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones, 2002 Apr;7(2):167-76.
93. Miron T, Vancompernolle K, Vandekerckhove J, Wilchek M, Geiger B. A 25-kd inhibitor of actin polymerization is a low-molecular mass heat-shock protein. J Cell Biol. 1991; 114(2):255-61.
94. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J, Lutsch G. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem. 1994; 269(32):20780-4.
95. Guay J, Lambert H, GingrasBreton G, Lavoie JN, Huot J, Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci. 1997; 110(Pt 3):357-68.
96. Panasenko OO, Kim MV, Marston SB, Gusev NB. Interaction of the small heat shock protein with molecular mass 25 kDa (hsp25) with actin. Eur J Biochem. 2003 Mar; 270(5):892-901.
97. Pivovarova AV, Chebotareva NA, Chernik IS, Gusev NB, Levitsky DI. Small heat shock protein Hsp27 prevents heat-induced aggregation of F-actin by forming soluble complexes with denatured actin. FEBS J. 2007 Nov; 274(22):5937-48.
98. Schafer C, Clapp P, Welsh MJ, Benndorf R, Williams JA. HSP27 expression regulates CCK-induced changes of the actin cytoskeleton in CHO-CCK-A cells. Am J Physiol. 1999 Dec; 277(6 Pt 1):C1032-43.
99. Wang K, Spector A. a-crystallin stabilises actin filaments and prevents cytochalasin-induced depolymerisation in a phosphorylation-dependent manner. Eur J Biochem. 1996; 242:56-66.
100. Wieske M, Benndorf R, Behlke J, Dolling R, Grelle G, Bielka H, et al. Defined sequence segments of the small heat shock proteins HSP25 and alphaB-crystallin inhibit actin polymerization. Eur J Biochem. 2001 Apr; 268(7):2083-90.
101. Singh BN, Rao KS, Ramakrishna T, Rangaraj N, Rao Ch M. Association of alphaB-crystallin, a small heat shock protein, with actin: role in modulating actin filament dynamics in vivo. J Mol Biol. 2007 Feb 23; 366(3):756-67.
102. Iwaki T, Iwaki A, Tateishi J, Goldman JE. Sense and antisense modification of glial alpha B-crystallin production results in alterations of stress fiber formation and thermoresistance. J Cell Biol. 1994; 125(6):1385-93.
103. Gopalakrishnan S, Takemoto L. Binding of actin to lens alpha crystallins. Curr Eye Res. 1992;11(9):929-33.
104. Brophy CM, Lamb S, Graham A. The small heat shock-related protein-20 is an actin-associated protein. J Vasc Surg. 1999; 29(2):326-33.
105. Bukach OV, Marston SB, Gusev NB. Small heat shock protein with apparent molecular mass 20 kDa (Hsp20, HspB6) is not a genuine actin-binding protein. J Muscle Res Cell Motil. 2005;26(4-5):175-81.
106. Geeves MA, Fedorov R, Manstein DJ. Molecular mechanism of actomyosin-based motility. Cell Mol Life Sci. 2005 Jul; 62(13):1462-77.
107. Nozais M, Bechet JJ, Houadjeto M. Inactivation, subunit dissociation, aggregation, and unfolding of myosin subfragment 1 during guanidine denaturation. Biochemistry, 1992 Feb 4; 31(4):1210-5.
108. Melkani GC, Cammarato A, Bernstein SI. AlphaB-crystallin maintains skeletal muscle myosin enzymatic activity and prevents its aggregation under heat-shock stress. J Mol Biol. 2006 May 5; 358(3):635-45.
109. Yoshioka M, Tanaka H, Shono N, Snyder EE, Shindo M, St-Amand J. Serial analysis of gene expression in the skeletal muscle of endurance athletes compared to sedentary men. FASEB J. 2003 Oct; 17(13):1812-9.
110. Tskhovrebova L, Trinick J. Titin: properties and family relationships. Nat Rev Mol Cell Biol. 2003 Sep; 4(9):679-89.
111. Granzier HL, Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res. 2004 Feb 20;94(3):284-95.
112. Linke WA, Granzier H. A spring tale: new facts on titin elasticity. Biophys J. 1998 Dec; 75(6):2613-4.
113. Wu Y, Cazorla O, Labeit D, Labeit S, Granzier H. Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J Mol Cell Cardiol. 2000 Dec; 32(12):2151-62.
114. Helmes M, Trombitas K, Centner T, Kellermayer M, Labeit S, Linke WA, et al. Mechanically driven contour-length adjustment in rat cardiac titin's unique N2B sequence: titin is an adjustable spring. Circ Res. 1999 Jun 11; 84(11):1339-52.
115. Golenhofen N, Arbeiter A, Koob R, Drenckhahn D. Ischemia-induced association of the stress protein alpha B-crystallin with I-band portion of cardiac titin. J Mol Cell Cardiol. 2002 Mar;34(3):309-19.
116. Bullard B, Ferguson C, Minajeva A, Leake MC, Gautel M, Labeit D, et al. Association of the chaperone alphaB-crystallin with titin in heart muscle. J Biol Chem. 2004 Feb 27; 279(9):7917-24.
117. Zhu Y, Bogomolovas J, Labeit S, Granzier H. Single molecule force spectroscopy of the cardiac titin N2B element: effects of the molecular chaperone alphaB-crystallin with disease-causing mutations. J Biol Chem. 2009 May 15; 284(20):13914-23.
118. Golenhofen N, Perng MD, Quinlan RA, Drenckhahn D. Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle. Histochem Cell Biol. 2004 Nov; 122(5):415-25.
119. Kumarapeli AR, Wang X. Genetic modification of the heart: chaperones and the cytoskeleton. J Mol Cell Cardiol. 2004 Dec;37(6):1097-109.
120. Launay N, Goudeau B, Kato K, Vicart P, Lilienbaum A. Cell signaling pathways to alphaB-crystallin following stresses of the cytoskeleton. Exp Cell Res. 2006 Nov 1;312(18):3570-84.
121. Inagaki N, Hayashi T, Arimura T, Koga Y, Takahashi M, Shibata H, et al. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun. 2006 Apr 7; 342(2):379-86.
122. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002 Feb;30(2):201-4.
123. Thedieck C, Kalbacher H, Kratzer U, Lammers R, Stevanovic S, Klein G. alpha B-crystallin is a cytoplasmic interaction partner of the kidney-specific cadherin-16. J Mol Biol. 2008 Apr 18; 378(1):145-53.
124. McLachlan RW, Yap AS. Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts. J Mol Med. 2007 Jun;85(6):545-54.
125. Fujita Y, Ohto E, Katayama E, Atomi Y. alphaB-Crystallin-coated MAP microtubule resists nocodazole and calcium-induced disassembly. J Cell Sci. 2004 Apr 1; 117(Pt 9):1719-26.
126. Ohto-Fujita E, Fujita Y, Atomi Y. Analysis of the alphaB-crystallin domain responsible for inhibiting tubulin aggregation. Cell Stress Chaperones. 2007 Summer; 12(2):163-71.
127. Hino M, Kurogi K, Okubo MA, Murata-Hori M, Hosoya H. Small heat shock protein 27 (HSP27) associates with tubulin/microtubules in HeLa cells. Biochem Biophys Res Commun. 2000 Apr 29; 271(1):164-9.
128. Arai H, Atomi Y. Chaperone activity of alpha B-crystallin suppresses tubulin aggregation through complex formation. Cell Structure and Function, 1997; 22(5):539-44.
129. Kato K, Ito H, Inaguma Y, Okamoto K, Saga S. Synthesis and accumulation of alpha-b-crystallin in c6 glioma-cells is induced by agents that promote the disassembly of microtubules. Journal of Biological Chemistry, 1996;271(43):26989-94.
130. Day RM, Gupta JS, MacRae TH. A small heat shock/alpha-crystallin protein from encysted Artemia embryos suppresses tubulin denaturation. Cell Stress Chaperones. 2003 Summer; 8(2):183-93.
131. Xi JH, Bai F, McGaha R, Andley UP. Alpha-crystallin expression affects microtubule assembly and prevents their aggregation. FASEB J. 2006 May;20(7):846-57.
132. Bluhm WF, Martin JL, Mestril R, Dillmann WH. Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes. Am J Physiol. 1998;275(6 Pt 2):H2243-9.
133. Ghosh JG, Houck SA, Clark JI. Interactive domains in the molecular chaperone human alphaB crystallin modulate microtubule assembly and disassembly. PLoS One, 2007;2(6):e498.
134. Ghosh JG, Houck SA, Clark JI. Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins. Int J Biochem Cell Biol. 2008;40(5):954-67.
135. Bagneris C, Bateman OA, Naylor CE, Cronin N, Boelens WC, Keep NH, et al. Crystal Structures of alpha-Crystallin Domain Dimers of alphaB-Crystallin and Hsp20. J Mol Biol. 2009 Jul 30.
136. Bova MP, Ding LL, Horwitz J, Fung BK. Subunit exchange of alphaA-crystallin. J Biol Chem. 1997;272(47):29511-7.
137. Shashidharamurthy R, Koteiche HA, Dong J, McHaourab HS. Mechanism of chaperone function in small heat shock proteins: dissociation of the HSP27 oligomer is required for recognition and binding of destabilized T4 lysozyme. J Biol Chem. 2005 Feb 18;280(7):5281-9.
138. Aquilina JA, Benesch JL, Ding LL, Yaron O, Horwitz J, Robinson CV. Phosphorylation of alphaB-crystallin alters chaperone function through loss of dimeric substructure. J Biol Chem. 2004 Jul 2;279(27):28675-80.
139. Jaya N, Garcia V, Vierling E. Substrate binding site flexibility of the small heat shock protein molecular chaperones. Proc Natl Acad Sci U S A. 2009 Aug 26.
140. van Montfort R, Slingsby C, Vierling E. Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv Protein Chem. 2001;59:105-56.
141. van Montfort RL, Basha E, Friedrich KL, Slingsby C, Vierling E. Crystal structure and assembly of a eukaryotic small heat shock protein. Nat Struct Biol. 2001 Dec;8(12):1025-30.
142. Liu L, Ghosh JG, Clark JI, Jiang S. Studies of alphaB crystallin subunit dynamics by surface plasmon resonance. Anal Biochem. 2006 Mar 15;350(2):186-95.
143. Friedrich KL, Giese KC, Buan NR, Vierling E. Interactions between small heat shock protein subunits and substrate in small heat shock protein-substrate complexes. J Biol Chem. 2004 Jan 9;279(2):1080-9.
144. Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005 Mar;62(6):670-84.
145. Horwich AL, Fenton WA, Chapman E, Farr GW. Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol. 2007;23:115-45.
146. Sathish HA, Stein RA, Yang G, McHaourab HS. Mechanism of chaperone function in small heat-shock proteins. Fluorescence studies of the conformations of T4 lysozyme bound to alphaB-crystallin. J Biol Chem. 2003 Nov 7;278(45):44214-21.
147. Ahrman E, Lambert W, Aquilina JA, Robinson CV, Emanuelsson CS. Chemical cross-linking of the chloroplast localized small heat-shock protein, Hsp21, and the model substrate citrate synthase. Protein Sci. 2007 Jul;16(7):1464-78.
148. Ghosh JG, Shenoy AK, Jr., Clark JI. Interactions between important regulatory proteins and human alphaB crystallin. Biochemistry, 2007 May 29;46(21):6308-17.
149. Cheng G, Basha E, Wysocki VH, Vierling E. Insights into small heat shock protein and substrate structure during chaperone action derived from hydrogen/deuterium exchange and mass spectrometry. J Biol Chem. 2008 Sep 26;283(39):26634-42.
150. Kim KK, Kim R, Kim SH. Crystal structure of a small heat-shock protein. Nature, 1998;394(6693):595-9.
151. Haley DA, Horwitz J, Stewart PL. The small heat-shock protein, alphaB-crystallin, has a variable quaternary structure. J Mol Biol. 1998;277(1):27-35.
152. Aquilina JA, Benesch JL, Bateman OA, Slingsby C, Robinson CV. Polydispersity of a mammalian chaperone: mass spectrometry reveals the population of oligomers in alphaB-crystallin. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10611-6.
153. Rajasekaran NS, Connell P, Christians ES, Yan LJ, Taylor RP, Orosz A, et al. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell, 2007 Aug 10;130(3):427-39.
154. Ghosh JG, Estrada MR, Clark JI. Interactive domains for chaperone activity in the small heat shock protein, human alphaB crystallin. Biochemistry, 2005 Nov 15;44(45):14854-69.
155. Eswar N, Eramian D, Webb B, Shen MY, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol. 2008;426:145-59.
156. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32.
157. Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68.
158. Dierick I, Baets J, Irobi J, Jacobs A, De Vriendt E, Deconinck T, et al. Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain, 2008 May;131(Pt 5):1217-27.
159. Houlden H, Laura M, Wavrant-De Vrieze F, Blake J, Wood N, Reilly MM. Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology, 2008 Nov 18;71(21):1660-8.
160. James PA, Rankin J, Talbot K. Asymmetrical late onset motor neuropathy associated with a novel mutation in the small heat shock protein HSPB1 (HSP27). J Neurol Neurosurg Psychiatry, 2008 Apr;79(4):461-3.
161. Tang B, Liu X, Zhao G, Luo W, Xia K, Pan Q, et al. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease. Arch Neurol. 2005 Aug;62(8):1201-7.
162. Ikeda Y, Abe A, Ishida C, Takahashi K, Hayasaka K, Yamada M. A clinical phenotype of distal hereditary motor neuronopathy type II with a novel HSPB1 mutation. J Neurol Sci. 2009 Feb 15;277(1-2):9-12.
163. Ackerley S, James PA, Kalli A, French S, Davies KE, Talbot K. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet. 2006 Jan 15;15(2):347-54.
164. Kijima K, Numakura C, Goto T, Takahashi T, Otagiri T, Umetsu K, et al. Small heat shock protein 27 mutation in a Japanese patient with distal hereditary motor neuropathy. J Hum Genet. 2005;50(9):473-6.
165. Dierick I, Irobi J, Janssens S, Theuns J, Lemmens R, Jacobs A, et al. Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response. Hum Mutat. 2007 Aug;28(8):830.
166. Pras E, Frydman M, Levy-Nissenbaum E, Bakhan T, Raz J, Assia EI, et al. A nonsense mutation (W9X) in CRYAA causes autosomal recessive cataract in an inbred Jewish Persian family. Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3511-5.
167. Hansen L, Yao W, Eiberg H, Kjaer KW, Baggesen K, Hejtmancik JF, et al. Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8. Invest Ophthalmol Vis Sci. 2007 Sep;48(9):3937-44.
168. Devi RR, Yao W, Vijayalakshmi P, Sergeev YV, Sundaresan P, Hejtmancik JF. Crystallin gene mutations in Indian families with inherited pediatric cataract. Mol Vis. 2008;14:1157-70.
169. Graw J, Klopp N, Illig T, Preising MN, Lorenz B. Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):912-9.
170. Mackay DS, Andley UP, Shiels A. Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q. Eur J Hum Genet. 2003 Oct;11(10):784-93.
171. Khan AO, Aldahmesh MA, Meyer B. Recessive congenital total cataract with microcornea and heterozygote carrier signs caused by a novel missense CRYAA mutation (R54C). Am J Ophthalmol. 2007 Dec;144(6):949-52.
172. Santhiya ST, Soker T, Klopp N, Illig T, Prakash MV, Selvaraj B, et al. Identification of a novel, putative cataract-causing allele in CRYAA (G98R) in an Indian family. Mol Vis. 2006;12:768-73.
173. Litt M, Kramer P, LaMorticella DM, Murphey W, Lovrien EW, Weleber RG. Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet. 1998;7(3):471-4.
174. Beby F, Commeaux C, Bozon M, Denis P, Edery P, Morle L. New phenotype associated with an Arg116Cys mutation in the CRYAA gene: nuclear cataract, iris coloboma, and microphthalmia. Arch Ophthalmol. 2007 Feb;125(2):213-6.
175. Vanita V, Singh JR, Hejtmancik JF, Nuernberg P, Hennies HC, Singh D, et al. A novel fan-shaped cataract-microcornea syndrome caused by a mutation of CRYAA in an Indian family. Mol Vis. 2006;12:518-22.
176. Richter L, Flodman P, Barria von-Bischhoffshausen F, Burch D, Brown S, Nguyen L, et al. Clinical variability of autosomal dominant cataract, microcornea and corneal opacity and novel mutation in the alpha A crystallin gene (CRYAA). Am J Med Genet A. 2008 Apr 1;146(7):833-42.
177. Gu F, Luo W, Li X, Wang Z, Lu S, Zhang M, et al. A novel mutation in AlphaA-crystallin (CRYAA) caused autosomal dominant congenital cataract in a large Chinese family. Hum Mutat. 2008 May;29(5):769.
178. Liu M, Ke T, Wang Z, Yang Q, Chang W, Jiang F, et al. Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family. Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3461-6.
179. Safieh LA, Khan AO, Alkuraya FS. Identification of a novel CRYAB mutation associated with autosomal recessive juvenile cataract in a Saudi family. Mol Vis. 2009;15:980-4.
180. Liu Y, Zhang X, Luo L, Wu M, Zeng R, Cheng G, et al. A novel alphaB-crystallin mutation associated with autosomal dominant congenital lamellar cataract. Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1069-75.
181. Berry V, Francis P, Reddy MA, Collyer D, Vithana E, MacKay I, et al. Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet. 2001 Nov;69(5):1141-5.
182. Nicolaou P, Knoll R, Haghighi K, Fan GC, Dorn GW, 2nd, Hasenfub G, et al. Human mutation in the anti-apoptotic heat shock protein 20 abrogates its cardioprotective effects. J Biol Chem. 2008 Nov 28;283(48):33465-71.
183. Tang BS, Zhao GH, Luo W, Xia K, Cai F, Pan Q, et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet. 2005 Feb;116(3):222-4.
184. Fontaine JM, Rest JS, Welsh MJ, Benndorf R. The sperm outer dense fiber protein is the 10th member of the superfamily of mammalian small stress proteins. Cell Stress Chaperones, 2003 Spring;8(1):62-9.
185. Müller M, Bhattacharya SS, Moore T, Prescott Q, Wedig T, Herrmann H, et al. Dominant cataract formation in association with a vimentin assembly disrupting mutation. Hum Mol Genet. 2009 Mar 15;18(6):1052-7.
186. Ramachandran RD, Perumalsamy V, Hejtmancik JF. Autosomal recessive juvenile onset cataract associated with mutation in BFSP1. Hum Genet. 2007 May;121(3-4):475-82.
187. Jakobs PM, Hess JF, FitzGerald PG, Kramer P, Weleber RG, Litt M. Autosomal-Dominant Congenital Cataract Associated with a Deletion Mutation in the Human Beaded Filament Protein Gene BFSP2. Am J Hum Genet. 2000;66(4):1432-6.
188. Zhang Q, Guo X, Xiao X, Yi J, Jia X, Hejtmancik JF. Clinical description and genome wide linkage study of Y-sutural cataract and myopia in a Chinese family. Mol Vis. 2004 Nov 17;10:890-900.
189. Cui X, Gao L, Jin Y, Zhang Y, Bai J, Feng G, et al. The E233del mutation in BFSP2 causes a progressive autosomal dominant congenital cataract in a Chinese family. Mol Vis. 2007;13:2023-9.
190. Conley YP, Erturk D, Keverline A, Mah TS, Keravala A, Barnes LR, et al. A Juvenile-Onset, Progressive Cataract Locus on Chromosome 3q21-q22 Is Associated with a Missense Mutation in the Beaded Filament Structural Protein-2. Am J Hum Genet. 2000;66(4):1426-31.
191. Ma X, Li FF, Wang SZ, Gao C, Zhang M, Zhu SQ. A new mutation in BFSP2 (G1091A) causes autosomal dominant congenital lamellar cataracts. Mol Vis. 2008; 14:1906-11.
192. De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol. 2001 Feb;49(2):245-9.
193. Perez-Olle R, Jones ST, Liem RK. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum Mol Genet. 2004 Oct 1; 13(19):2207-20.
194. Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, et al. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene. Arch Neurol. 2007 Jul;64(7):966-70.
195. Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain, 2003 Mar; 126(Pt 3):590-7.
196. Leung CL, Nagan N, Graham TH, Liem RK. A novel duplication/insertion mutation of NEFL in a patient with Charcot-Marie-Tooth disease. Am J Med Genet A. 2006 May 1; 140(9):1021-5.
197. Georgiou DM, Zidar J, Korosec M, Middleton LT, Kyriakides T, Christodoulou K. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics, 2002 Oct;4(2):93-6.
198. Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, et al. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology, 2004 Apr 27; 62(8):1429-31.
199. Abe A, Numakura C, Saito K, Koide H, Oka N, Honma A, et al. Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet. 2009; 54(2):94-7.
200. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain, 2004 Feb; 127(Pt 2):439-51.
201. Bergman JE, Veenstra-Knol HE, van Essen AJ, van Ravenswaaij CM, den Dunnen WF, van den Wijngaard A, et al. Two related Dutch families with a clinically variable presentation of cardioskeletal myopathy caused by a novel S13F mutation in the desmin gene. Eur J Med Genet. 2007 Sep-Oct;50(5):355-66.
202. Pica EC, Kathirvel P, Pramono ZA, Lai PS, Yee WC. Characterization of a novel S13F desmin mutation associated with desmin myopathy and heart block in a Chinese family. Neuromuscul Disord. 2008 Feb; 18(2):178-82.
203. Arbustini E, Pasotti M, Pilotto A, Pellegrini C, Grasso M, Previtali S, et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail. 2006 Aug; 8(5):477-83.
204. Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation, 2007 Mar 13; 115(10):1244-51.
205. Kostareva A, Gudkova A, Sjoberg G, Kiselev I, Moiseeva O, Karelkina E, et al. Desmin mutations in a St. Petersburg cohort of cardiomyopathies. Acta Myol. 2006 Dec; 25(3):109-15.
206. Munoz-Marmol AM, Strasser G, Isamat M, Coulombe PA, Yang Y, Roca X, et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy [In Process Citation]. Proc Natl Acad Sci U S A. 1998;95(19):11312-7.
207. Park KY, Dalakas MC, Goebel HH, Ferrans VJ, Semino-Mora C, Litvak S, et al. Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet. 2000 Nov; 37(11):851-7.
208. Schroder R, Vrabie A, Goebel HH. Primary desminopathies. J Cell Mol Med. 2007 May-Jun; 11(3):416-26.
209. Vrabie A, Goldfarb LG, Shatunov A, Nagele A, Fritz P, Kaczmarek I, et al. The enlarging spectrum of desminopathies: new morphological findings, eastward geographic spread, novel exon 3 desmin mutation. Acta Neuropathol. 2005 Apr; 109(4):411-7.
210. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med. 2000 Mar 16;342(11):770-80.
211. Goudeau B, Rodrigues-Lima F, Fischer D, Casteras-Simon M, Sambuughin N, de Visser M, et al. Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat. 2006 Sep;27(9):906-13.
212. Schroder R, Goudeau B, Simon MC, Fischer D, Eggermann T, Clemen CS, et al. On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet. 2003 Mar 15; 12(6):657-69.
213. Carlsson L, Fischer C, Sjoberg G, Robson RM, Sejersen T, Thornell LE. Cytoskeletal derangements in hereditary myopathy with a desmin L345P mutation. Acta Neuropathol. 2002 Nov;104(5):493-504.
214. Sjoberg G, Saavedra-Matiz CA, Rosen DR, Wijsman EM, Borg K, Horowitz SH, et al. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet. 1999 Nov; 8(12):2191-8.
215. Walter MC, Reilich P, Huebner A, Fischer D, Schroder R, Vorgerd M, et al. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain, 2007 Jun;130(Pt 6):1485-96.
216. Bar H, Fischer D, Goudeau B, Kley RA, Clemen CS, Vicart P, et al. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet. 2005 May 15; 14(10):1251-60.
217. Fidzianska A, Kotowicz J, Sadowska M, Goudeau B, Walczak E, Vicart P, et al. A novel desmin R355P mutation causes cardiac and skeletal myopathy. Neuromuscul Disord. 2005 Aug; 15(8):525-31.
218. Dagvadorj A, Goudeau B, Hilton-Jones D, Blancato JK, Shatunov A, Simon-Casteras M, et al. Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin c-terminal alpha-helical segment. Muscle Nerve, 2003 Jun; 27(6):669-75.
219. Kaminska A, Strelkov SV, Goudeau B, Olive M, Dagvadorj A, Fidzianska A, et al. Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet. 2004 Feb;114(3):306-13.
220. Olive M, Armstrong J, Miralles F, Pou A, Fardeau M, Gonzalez L, et al. Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene. Neuromuscul Disord. 2007 Jun;17(6):443-50.
221. Sugawara M, Kato K, Komatsu M, Wada C, Kawamura K, Shindo PS, et al. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology, 2000 Oct 10;55(7):986-90.
222. Goudeau B, Dagvadorj A, Rodrigues-Lima F, Nedellec P, Casteras-Simon M, Perret E, et al. Structural and functional analysis of a new desmin variant causing desmin-related myopathy. Hum Mutat. 2001 Nov; 18(5):388-96.
223. Park KY, Dalakas MC, Semino-Mora C, Lee HS, Litvak S, Takeda K, et al. Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation. Clin Genet. 2000 Jun; 57(6):423-9.
224. Olive M, Goldfarb L, Moreno D, Laforet E, Dagvadorj A, Sambuughin N, et al. Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies. J Neurol Sci. 2004 Apr 15; 219(1-2):125-37.
225. Dagvadorj A, Olive M, Urtizberea JA, Halle M, Shatunov A, Bonnemann C, et al. A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol. 2004 Feb; 251(2):143-9.
226. Pruszczyk P, Kostera-Pruszczyk A, Shatunov A, Goudeau B, Draminska A, Takeda K, et al. Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. Int J Cardiol. 2007 Apr 25;117(2):244-53.
227. Li D, Tapscoft T, Gonzalez O, Burch PE, Quinones MA, Zoghbi WA, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation, 1999;100(5):461-4.
228. Tesson F, Sylvius N, Pilotto A, Dubosq-Bidot L, Peuchmaurd M, Bouchier C, et al. Epidemiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy. Eur Heart J. 2000 Nov; 21(22):1872-6.
229. Bar H, Goudeau B, Walde S, Casteras-Simon M, Mucke N, Shatunov A, et al. Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies. Hum Mutat. 2007 Apr; 28(4):374-86.
230. Muntoni F, Bonne G, Goldfarb LG, Mercuri E, Piercy RJ, Burke M, et al. Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain, 2006 May; 129(Pt 5):1260-8.